Adverse effects · people with AMD
Antioxidant multivitamin and mineral supplement may leads to lower adverse effects compared with placebo or no treatment (low certainty).
1 finding from 1 review
Resource use and costs · people with AMD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression to late AMD (neovascular AMD, geographic atrophy or both) · people with AMD
Lutein with or without zeaxanthin showed no clear difference in progression to late AMD (neovascular AMD, geographic atrophy, or both) compared with placebo (low certainty).
1 finding from 1 review
Progression to neovascular AMD · people with AMD
Lutein with or without zeaxanthin showed no clear difference in progression to neovascular AMD compared with placebo (low certainty).
1 finding from 1 review
Clinical efficacy (RR > 1 is favored) · Participants with acute bacterial conjunctivitis
1 finding from 1 review
no estimate extracted
4 participants
Moderate
Microbiological efficacy (RR > 1 favored) · Participants with acute bacterial conjunctivitis
1 finding from 1 review
no estimate extracted
8 participants
Moderate
Treatment incompletion (RR < 1 favored) · Participants with acute bacterial conjunctivitis
Antibiotics probably leads to lower treatment incompletion (RR < 1 favored) compared with placebo (moderate certainty).
1 finding from 1 review
Persistent clinical infection after one course of treatment (RR < 1 favored) · Participants with acute bacterial conjunctivitis
Antibiotics probably leads to lower persistent clinical infection after one course of treatment (RR < 1… compared with placebo (moderate certainty).
1 finding from 1 review
Cost‐effectiveness of treatment · Participants with acute bacterial conjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment‐associated ocular complications (RR < 1 or RD ≤ 0 favored) · Participants with acute bacterial conjunctivitis
It is very uncertain whether antibiotics changes treatment‐associated ocular complications (RR < 1 or RD ≤ 0 favored) compared with placebo (very low certainty).
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Treatment‐associated systemic complications (RR < 1 favored) · Participants with acute bacterial conjunctivitis
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Mean change in BCVA at 1 month (logMAR) · people with acute non‐arteritic CRAO
1 finding from 1 review
Quality of life measures at 1 month · people with acute non‐arteritic CRAO
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events at 1 month · people with acute non‐arteritic CRAO
1 finding from 1 review
Treatment success: improvement in the angle of strabismus at 6 months · children with infantile esotropia
It is very uncertain whether surgery changes treatment success: improvement in the angle of strabismus at 6 months compared with botulinum neurotoxin injections (very low certainty).
1 finding from 1 review
Presence and quality of binocularity at 6 months · children with infantile esotropia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects (severe, minor) at 6 months · children with infantile esotropia
1 finding from 1 review
Treatment success: improvement in the angle of strabismus at 6 months · children with infantile esotropia
1 finding from 1 review
Presence and quality of binocularity at 6 months · children with infantile esotropia
1 finding from 1 review
Adverse effects (severe, minor) at 6 months · children with infantile esotropia
1 finding from 1 review